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Abstract
We consider mathematical modeling of blood glucose-insulin regulatory system with the
additional effect of the secreted insulin by the pancreatic beta cells and in the presence of an
external energy input to such system. Such modeling system is investigated to determine the
time-dependent nonlinear dynamics that take place by the quantities, which represent the glucose
and insulin concentrations in the blood, insulin action as well as in the absence or presence of
secreted insulin due to the pancreatic beta cells. Using both analytical and numerical procedures,
we determine such quantities versus time for both diabetes patients and normal human and for
different values of the parameters. We find that the nonlinear effect of the dynamics of the
investigated regulatory system increases the values of the insulin action and the glucose and
insulin concentrations. In the absence of the beta cells effects, which can correspond to the case
of severe type 1 diabetes, the plasma glucose is higher and the insulin action and the insulin
concentration are less active than the corresponding ones for the case in the presence of beta
cells, which is relevant for type 2 diabetes or moderate type 1 diabetes patients. For the present
system, smaller values of the parameters of the model, which represent kinetics of the glucose
and insulin action, insulin sensitivity, insulin secretion enhancement and the plasma insulin
decay rate, can lead to notably lower values of the glucose concentration. In the presence of the
secreted insulin by the pancreatic beta cells the insulin action and the insulin concentration are
more effective to reduce the blood glucose, which can help to improve the diabetes patient’s
health.
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1. Introduction
Diabetes is a critical health problem among Americans. In 2015, diabetes was the seventh
leading cause of death in the U.S., according to the Centers for Disease and Prevention. A most
recent report showed that approximately more than 100 million U.S. adults have diabetes or prediabetes. Diabetes and pre-diabetes are medical conditions that can affect an individual at any
age and must be diagnosed and treated promptly. However, many Americans failed to treat this
condition. Only about 11.6 percent of Americans with pre-diabetes were aware of their
conditions and approximately, 1 in 4 adults did not know that they had diabetes. An early
diagnosis is highly important as pre-diabetes can lead to type 2 diabetes and diabetes can lead to
heart problems and death.
Diabetes is known to be a health condition where the blood glucose levels are too high. This
medical problem can be caused by different reasons. One of the reasons might be by a failure of
an individual’s pancreas to produce a hormone that helps transporting the glucose that the person
eats into the body’s cells as an energy source; and this hormone is called insulin. More clearly,
under the early stage of the diabetes illness, the individual’s immune system can often attack and
damage or destroy the pancreatic cells that help to regulate the level of glucose in the blood. As a
result, the glucose builds up in the individual’s bloodstream. If this is the case, an individual
would be diagnosed with type 1 diabetes. Another reason might be that an individual’s body
might not produce enough insulin or not be able to use insulin properly, which also can lead to a
higher glucose level in bloodstream than the normal glucose level. Whenever this is the case, an
individual would be diagnosed with type 2 diabetes.
On the other hand, pre-diabetes is a condition where the blood sugar is higher than normal, but it
is not high enough to be diagnosed as diabetes. Individuals with pre-diabetes are at higher risk of
developing type 2 diabetes if it is left untreated. As we referred to before, diabetes can lead to
several health complications including heart problems and death. Therefore, early detection is
important for the health recovery of the diabetic patients. There are blood tests that can help to
detect whether an individual has diabetes or not.
In the last several decades there have been a number of research studies on the diabetes illness,
which can be of the type 1 diabetes or type 2 diabetes, and the associated blood hormones using
different approaches (Bergman et al. 1979, 1980; Bergman and Cobelli 1980; Toffolo et al.
1980; Ni et al. 1997; Mitsis et al. 2009; Gyorgy et al. 2015; Mourad et al. 2015; Rietschoten et
al. 2015; Turksoy et al. 2016; Sara and Annette 2016; Hassan et al. 2017; Gomez et al. 2017;
Forlenza et al. 2019). Bergman et al. (1979) and Bergman and Cobelli (1980) developed a model
for the motion of the glucose and insulin hormones. It has been referred to as the minimal model
since it was simple enough with the least amount of the biological complexities. The minimal
model is often referred to as an open-loop model since it does not contain an equation for the
insulin secretion due to the pancreatic beta cells, which can operate when the glucose plasma
concentration is elevated.
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Mitsis et al. (2009) considered, in particular, a so-called closed-loop model that combined part of
the minimal model with an equation for the insulin secretion by the beta cells. These authors
developed a Volterra type computational model that was tested versus their closed-loop model,
which did not include an equation for the plasma insulin concentration. Instead, in their
computational model they used a collection of data points to represent the plasma insulin
concentration term in the retained part of the minimal model. Closed-loop system can also be due
to an external source for the insulin injection or for pumping insulin by a device attached to the
diabetes patient’s body as in the case of artificial pancreas device system described by Sara and
Annette (2016). These authors described the operation by such device, which consists of an
insulin pump and a glucose monitor all controlled by a digital controller. Such device has been
used mainly for the patients with very severe type 1 diabetes, where the pancreatic beta cells are
completely inactive or destroyed.
Hassan et al. (2017) studied a closed-loop type system that was based on a modified minimal
model, where they added an external insulin function to the equation for the plasma insulin
concentration. They carried out some computational work to determine the amount of insulin
input that may be needed for a patient with specified glucose concentration.
In the present paper we develop a new mathematical model to determine the nonlinear dynamics
of the blood hormones in the regulatory system of humans. Our model is an extension of the
minimal model and the previous models due to Mitsis et al. (2009) and Hassan et al. (2017). It
takes into consideration for the first time the specific nonlinear system of differential equations
for the time evolution of the plasma glucose concentration, insulin excitable tissue due to glucose
uptake activity, which refers to as insulin action, plasma insulin concentration and also the
secreted insulin due to the pancreatic beta cells that becomes effective if the plasma glucose
concentration is elevated beyond some value. In addition, the equation for the plasma glucose of
our modeling system contains a source function that provides external energy input to the
patient’s body.
Thus, our modeling system is a closed-loop system. In the presence of the pancreatic beta cells,
our system is a closed-loop system that provides for the first time the external energy input for
the glucose as well as internal insulin input due to the pancreatic beta cells so that our model can
be applicable to both type 2 diabetes and moderate type 1 diabetes patients cases, where the
pancreatic beta cells can operate. In the absence of the pancreatic beta cells that we also
considered in the present study in order to determine the results in the absence of the beta cells,
our modeling system is also a closed-loop system due to presence of the external energy input,
but then the modeling system can be only relevant to the severe type 1 diabetes patient case.
Next, we used both analytical and numerical procedures to determine the solution for such
nonlinear system under particular conditions for different levels of diabetes in patients, while
analyzing the interaction of the considered hormones in the regulatory system. We found that the
nonlinear effect due to the nonlinear modeling system for the glucose-insulin dynamics can be
notable. Our modeling system provided details of the nonlinear dynamics of the considered
blood hormones and the roles play by the glucose concentration, insulin action, insulin
concentration, insulin secretion of the pancreatic beta cells and the external energy input during
the time evolution of the hormones.
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2. Modeling system
Our modeling system for the glucose-insulin dynamics is partially based on a so-called minimal
model (Bergman et al. 1979) that is simple enough with least biological complexities. The
original minimal model has been applied by several authors in the past including notable ones
due to Bergman and Cobelli (1980), Toffolo et al. (1980) and Bergman et al. (1980) for the
noninvasive insulin sensitivity evaluation. In the present paper we make use of such model and
include additional important effects of external energy input and presence of the pancreatic beta
cells that can generate additional insulin due to the high elevation of glucose.
Our governing modeling system is given below
dG/dt =-[P1 +X(t)]G(t)+P1 Gb+D(t),

(1a)

dX/dt =-P2 X(t)+P3 [I(t)-Ib +r(t)],

(1b)

dI/dt =P4[G(t)-P5]+ t –P6[I(t)-Ib ],

(1c)

dr/dt =-a r(t)+[G(t)-Gb -]+,

(1d)

G=Gb , I=Ib , X=0, r =0 at t =0,

(1e)

where for any function f(t), we designate that [ f ]+ = f if f >0 and 0 otherwise. Here G is the
glucose concentration in the plasma with basal value Gb, where basal values are those that were
measured during a fasting period for the diabetes patient, X is the insulin action, I is the plasma
insulin concentration with basal value Ib, r is the secreted insulin by the pancreatic beta cells in
response to alteration in plasma glucose concentration, P1 and P2 are positive constants that are
referred to as, respectfully, kinetics of glucose and insulin action, P3 is a positive constant that is
referred to as insulin sensitivity coefficient, P4 is a positive constant representing contribution to
the plasma insulin concentration by the internal regulatory system, P5 is a positive constant
above which insulin is secreted, P6 is a positive constant representing plasma insulin decay rate,
D(t) is an external energy input to the patient’s body, which can be a form of imported food, and
can represent glucose absorption rate in the blood by the food intake, and here we use a modeling
form of it as a0 exp(-b0 t), where a0 and b0 are two positive constants of order unity, a is a
positive constant that is referred to as a kinetic constant,  is a positive constant that determines
rate of insulin secretion and  is a non-negative constant with value above which insulin due to
beta cells is operative.
The form that we chose for the input energy D(t) can be a reasonable modeling one for the
qualitative aspects of the glucose absorption rate in the blood as in the case of a meal taken by
the patient, when the impact of the energy input to the patient’s digestive system is higher first
and then its impact decreases with increasing time.
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The modeling equations (1a)-(1d) contain the non-negative constants parameters P1 –P6, a,  and
 that were defined above and include those defined in the minimal model (Mitsis et al. 2009;
Hassan et al. 2017) and in the pancreatic beta cells model (Mitsis et al. 2009). They are
measurable constants with the physiological range of values (Ni et al. 1997; Mitsis et al. 2009),
where the actual values can vary for different normal and patient cases.
In the following paragraphs, we provide some explanation of the modeling system (1a)-(1e), but
it should be noted that the equations (1a)-(1c) in the absence of both the external energy input
term D(t) and the governing equation for the insulin secretion r are basically equivalent to the
minimal model (Bergman et al. 1979) that we described before in the section 1.
The left-hand-side of the equation (1a) represents the time rate of change of the plasma glucose
concentration, and it balances with the sum of three terms in the right-hand-side of (1a). The first
term [-P1 (G-Gb )] represents the contribution of the glucose excess over its basal value on the
rate of change of the glucose, while the second term is the nonlinear (bilinear) term (–P1 X G)
that describes the effect of the insulin action to reduce the plasma glucose and, thus, has a
negative contribution to the rate of change of the glucose. The last term is the external energy
input that has a positive contribution to the rate of change of the glucose.
The left-hand-side of the equation (1b) represents the time rate of change of the insulin action,
and it balances with sum of three terms in the right-hand-side of (1b). The first term (-P2 X)
represents the contribution of the insulin action alone on the rate of change of the insulin action
and has a negative contribution. The second term [P3 (I-Ib)] represents the contribution of the
insulin concentration excess over its basal value on the rate of change of the insulin action. It has
a positive contribution only if the insulin concentration is above its basal value. The last term (P3
r) is the positive contribution on the rate of change of the insulin action by the secreted insulin
due to the pancreatic beta cells.
The left-hand-side of the equation (1c) represents the time rate of change of the plasma insulin
concentration, and it balances with sum of two terms in the right-hand-side of (1c). The first term
[P4 (G-P5)]+ t represents a positive contribution by the glucose to the time rate of increase of the
insulin concentration if the blood glucose is sufficiently large (G>P5), while the second tem [P6
(I-Ib)] represents contribution by the deviation of insulin concentration from its basal value to its
time rate of change.
The left-hand-side of the equation (1d) is the time rate of change of the secreted insulin by the
pancreatic beta cells, and it balances with the sum of two terms in the right-hand-side in (1d).
The first term (-a r) represents the contribution of the secreted insulin alone on its time rate of
change, while the second term (G-Gb -) represent a positive contribution by the deviation of
the glucose from its basal value to the time rate of increase of the secreted insulin if this glucose
excess from its basal value is sufficiently large (G-Gb>).
The initial conditions that are given in (1e) for the glucose and insulin concentrations in the
plasma are taken to be their corresponding basal values, which are usually those values measured
during the fasting conditions. We choose these basal values as the initial values of these
quantities by ignoring very short “transient” phase between the fasting and starting times of the
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motion (Mitsis et al. 2009). The initial conditions for X and r that are given in (1e) are taken as
zero since initially there is no action taken by the insulin and no secreted insulin is generated at
t=0.
As we already explained in the section 1, our modeling system (1a)-(1e) is a novel one that for
the first time investigates the nonlinear dynamics of four nonlinear differential equations for the
time-dependent motion due to the plasma glucose concentration, plasma insulin concentration,
insulin action and the secreted insulin by the pancreatic beta cells. In addition, our modeling
system includes the effect of an external energy input to the patient’s body. Thus, the results of
our dynamical investigation can be relevant for the motion of the hormones in the regulatory
systems for type 2 diabetes and moderate type 1 diabetes patients, where pancreatic beta cells
can operate.
Also to detect the dynamical results due to the presence of active pancreatic beta cells alone, we
also investigated the modeling system in the absence of the beta cells, where the corresponding
results can be relevant to severe type 1 diabetes patient case. We then compared the results
between the case in the presence of beta cells and the case in the absence of the beta cells, and
we were able to determine the effects due to the beta cells alone. In the previous section we
already reviewed the previous studies on the related subject, and in the section 4 we have
explained the significance of the present work as compared to the previous related studies.

3. Solution, results & discussion without beta cells effect
In this section we consider the system of equations (1a)-(1c) and the corresponding initial
conditions given in (1e) but with no presence of the beta cells effect on the insulin action, so that
r=0 in (1b). Thus, here we consider the case that the pancreatic beta cells of the patient are
completely inactive and cannot operate, which corresponds to the case of patient with severe
type 1 diabetes. We carried out our investigation using both analytical and numerical methods to
determine the solution for the stated system.

3.1. Analytical solution & results
For G P5, we considered both linear and nonlinear versions of the stated system, and we solved
them analytically which was done easily using separated variables approach for the homogenous
part of each equation plus a simple non-homogeneous term if the equation is non-homogeneous.
If G  P5 holds initially at t=0, then we find that both linear and nonlinear version of the system
yield
G=Gb +[a0 /(P1 –b0)][exp(-b0 t)-exp(-P1 t)], I=Ib, X=0 for GP5 at t=0.

(2a-c)

By direct substitution, the solution given by (2a-c) was verified to be the solution of the linear
version of the system (1a)-(1c) and (1e).
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It can be seen from this solution that the plasma insulin concentration stays at its basal value and
the insulin action remains zero. These results indicate that for the value of plasma glucose
concentration less than or equal to a threshold value, the insulin action as well as insulin
concentration are not effective since glucose in the plasma is not large enough to trigger extra
insulin production for countering the presence of the glucose concentration in the plasma.
If GP5 begins to hold at some value t0 >0 where G=G0, X=X0 and I=I0, then using the same type
of the stated analytical approach, we find the following solution for the linear case:
I=Ib+I0 exp[P6 (t0 –t)], X=c2 exp(-P2 t)+c4 exp(-P6 t),
G=Gb+ c6 exp(-P1 t)+c7 exp(-P2 t)+c8 exp(-P6 t)+c10 exp(-b0 t),

(2d-e)
(2f)

where
c4 =[(I0 –Ib)P3 exp(P6 t0)]/(P2 –P6), c2= X0 exp( P2 t0)-c4 exp[(P2 –P6 ) t0],
c7 =Gb c2/(P1–P2), c8=Gb c4/(P1–P6 ), c10 =a0 /(P1 –b0),
c6 =(G0 –Gb)exp(P1 t0)-c7 exp[(P1 –P2)t0]-c8 exp[(P1–P6)t0]-c10 exp [ (P1 –b0 )t0 ].

(2g-h)
(2i-k)
(2l)

By direct substitution to the governing system, we proved that (2d-f) is the solution to the linear
version of (1a-e).
For the nonlinear system, the solution for I and for X remain the same as the ones given in (2d-e).
However, the solution for G needs to be found using a different analytical method. We applied
the method of integration factor (Pontryagin 1962) to determine the expression for G(t). It is
given below:
G(t)=Gb +{[0t (t)R(t)dt]+(G0 –Gb)(t0)}/[(t)],

(2m)

where
(t)=exp[P1 t+(c2/P2)exp(-P2 t)+(c4 /P6)exp(-P6 t)], R(t)=Gb X(t)+a0 exp(-b0 t).

(2n-o)

3.2. Numerical solution & results
For both G<P5 and G P5, the system is also solved numerically for both linear and nonlinear
cases using Euler’s method (Ascher et al. 1995). In the case of G< P5, we did check our
numerical results versus the solution given in (2) to verify the numerical solution as well as to
check the reasonable value of the mesh distance, and we find very good agreement between the
numerical and analytical solutions. Thus, it was verified the correctness of our constructed code,
and, in addition, it showed the step size of 0.05 that we used in the simulation was quite
reasonable.
The present system of equations and initial conditions are for the time evolution of G, I and X
versus t. This system of differential equations represents the time rate of change of glucose and
insulin concentrations in the plasma together with the insulin action as the dependent variables.
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To obtain the numerical solution of this system, we used some collected data values for the
constant parameters of the governing system for both healthy person and diabetic patients. The
values of the parameters and constants for three patients and one normal person cases were
collected from some references (Ni et al. 1997; Mitsis et al. 2009; Hassan et al. 2017) that are
given below in Table 1:
Table 1. Parameters for a normal person and three diabetes patients
Parameter Normal
Patient 1
Patient 2
Patient3
0.031
0
0
0
P1
0.012
0.011
0.007
0.014
P2
0.00000492
0.0000053
0.00000216
0.00000994
P3
0.0039
0.0042
0.0038
0.0046
P4
79.035
80.2
77.578
82.937
P5
0.265
0.26
0.246
0.281
P6
70-80
70-80
70-80
70-80
Gb
7
7
7
7
Ib
291.2
220
200
180
G0
364.8
50
55
60
I0
In the present study we investigated only the cases where the initial conditions for the glucose
concentration and insulin concentration are the same as their basal values. For the case that the
initial conditions for the glucose and insulin concentrations can be different from the
corresponding basal values, then other initial conditions for G and I can be those that are given in
Table 1 as G0 and I0 (Hassan et al. 2017), but we did not consider such case in the present study.
For the analytical solution that was given in (2a) for G(t), which we found to agree very well
with the corresponding numerical solution for G < P5, we present here such result graphically as
is shown in Figure 1 for a normal person and for different values of the constant coefficients a0
and b0 in the expression for the energy input function D(t), which represents the glucose
absorption rate to the blood of the particular normal person with the values of the parameters and
the constants as given in table 1.
It can be seen from this Figure that initially the plasma glucose concentration increases from its
basal value due to the intake energy. The glucose concentration increases quickly with increasing
the magnitude of the energy input and then the glucose decreases with increasing t as the amount
of the intake energy is consumed by the person’s body. For sufficiently large values of t, the
glucose concentration then reaches its equilibrium value, which is its basal value.
As stated earlier and as a test of our numerical code, we also compared our numerical solution
for plasma glucose concentration, plasma insulin concentration and the insulin action subjected
to the same parameter and constant values as the corresponding ones that were considered for the
analytical solution (2a-c), and we found excellent agreement between the numerical solution and
the corresponding the analytical solution.
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Figure 1. Glucose versus time for normal person, where G1, G2 and G3 correspond, respectively, to the
values of (a0, b0) = (1, 1), (1, 2) and (2, 1)

Figure 2 presents the numerical solution for the glucose concentration versus time for the normal
person and for the same parameters values as those for Figure 1, but here the basal value for the
glucose is chosen as 80 since we wanted to determine the results for G > P5 that requires the
numerical approach be implemented as was explained before. It can be seen from this Figure that
the glucose concentration is raised up very quickly, reaches a maximum and then decreases

Figure 2. The same as in Figure 1 but for basal value of 80
sharply with increasing t. Its initial sharp increase in value is due to the presence of the energy
input, which is highest initially but decreases with increasing time. Then, a short time later, the
glucose concentration decreases with increasing time, which is due to the reduction in the value
of the energy input as well as the presence of insulin that increase quickly to reduce the presence
of high glucose.
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Figure 3 is the same as Figure 2 but for insulin action versus time. It can be seen from this
Figure

Figure 3. The same as in Figure 2 but for insulin action
that the insulin action arises to counteract the presence of the glucose and is stronger for the case
where the glucose concentration is higher in the plasma, and the rate of increase of the insulin
action is also higher for higher glucose concentration, which are expected biomedically.
Figure 4 is the same as Figure 2 but for the plasma insulin concentration. It can be seen from this

Figure 4. The same as in Figure 2 but for insulin concentration
Figure that initially the insulin concentration increases with time and is higher for higher glucose
concentration until at some value in time when it begins to decrease with increasing time.
Initially insulin concentation increases strongly with time in order to reduce the glucose
concentration that was built up initially and reaches a maximum due to the energy input, and
then the insulin concentration decreases at later time since the amount of glucose is reduced due
to the insulin impact, and the energy input also is reduced at such later in time.
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Figure 5 presents plasma glucose concentration for both linear and nonlinear system versus time
and for normal person with a0 =b0 =1. It can be seen from this Figure that the nonlinear effect is
important and lead to small increase in the value of the glucose concentration. The nonlinear
effect, which is present in (1a) is due to the product of glucose concentration and the insulin
action that is an effect caused by the insulin action to counteract the increase in the value of the
glucose concentration that subsequently can enhance the effect of the insulin action.
Figure 6 is the same as Figure 5 but for the insulin action versus time. It is seen the role of the
nonlinearity that enhances the insulin action, which we described earlier in relation to Figure 5.

Figure 5. Glucose versus time for linear (solid line) and nonlinear (dashed
line) cases for normal person with Gb =80 and a0 =b0 =1.0

However, it can be seen from this Figure that the effect of the nonlinearity is more significant for
the insulin action since the insulin action is a main part of the nonlinear term in the equation (1a)
that its role is to reduce the presence of the glucose concentration in the plasma whenever the
value of the plasma glucose concentration becomes high enough. As a result of notable effect of
the nonlinearity on the values of the insulin action shown in Figure 6, it is also expected that the
values of the plasma insulin concentration become significant due to the nonlinear effect. Our
next Figure 7 confirms such expectation.

Figure 6. The same as Figure 5 but for insulin action
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Figure 7 is the same as in Figure 5 but for the insulin concentration. It can be seen from this
Figure that the nonlinear effect that was shown to enhance the insulin action also increase
notably the value of the insulin concentration. We also generated data similar those that were
shown in Figures 5-7 but for the cases of the other patients, and we found similar results about
the nonlinear effect that were described above for the normal person case.

Figure 7. The same as in Figure 5 but for insulin concentration
It should be noted that while constructing graphs for linear and nonlinear systems for the case of
G > P5, it was noticed that the difference between these two systems is small. This is reasonable
due to the fact that the values for the insulin action are relatively small and thus do not have an
big impact on the nonlinear term in (1a), which represents the nonlinear interaction between the
insulin action and the glucose concentration.
Figure 8 presents the plasma glucose concentration versus time for the normal person, patient 2
and patient 3, where “A” and “N” in Figure indicate the solution, respectively, by analytical and
numerical procedures. It can be seen from this Figure that for the normal person the range of
values for the glucose concentration is about around the basal value, which is expected. For the
patient 2, the glucose concentration first increases slightly and then decreases, which is an
indication of the unstable condition mainly due to the smaller values of the parameters, which
include those that represent the kinetic of the glucose and insulin action, insulin sensitivity,
enhancing insulin secretion and decay rate, and such smaller values tend to reduce the glucose
concentration at some higher rate.
For the patient3, the values of the glucose slightly increase, which can be due to the larger values
of the stated parameters, but it notably reduces the value of the insulin action. It should also be
noted that in the case of patient 2, initially we had the condition of G > P5, which required to
determine the solution numerically for some interval in time t<t0, beyond which we observed that
G  P5 that we used the available analytical solution that was given in the sub-section 3.1.
Figure 9 is the same as Figure 8 but for the plasma insulin concentration versus time. It can be
seen from this Figure that in analogy to the results shown in Figure 8 for the plasma glucose
concentration, the insulin concentration increases slightly for the healthy person, but the rate of
change of the values of the insulin concentration that increases notably over some interval in
time and then decreases notably thereafter is an indication of unstable behavior in the case of the

AAM: Intern. J., Vol. 15, Issue 1 (June 2020)

183

patient 2. For the case of patient 3, the value of the insulin concentration remains basically the
same as its basal value.

Figure 8. Glucose concentration versus time for normal person (solid line), patient 2 (dashed-dot line)
and patient 3 (dashed line) for Gb =80 and a0 =b0 =1.0

Figure 9. The same as in Figure 8 but for insulin concentration

Figure 10. The same as Figure 8 but for insulin action
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Figure 10 is the same as in Figure 8 but for insulin action versus time. In analogy to Figures 8-9,
the insulin action increases by some relatively moderate amount for the normal person case,
while it increases notably and remain at higher values for the patient 2 that indicates relatively
more critical condition in this case. However, in the case of patient 3 the insulin action remains
very close to its initial condition of zero value, which is due to relatively large parameters values
for this patient that we described before.

4. Solution, results & discussion with beta cells effect
In this section we consider the system of equation (1a)-(1d) and their corresponding initial
conditions (1e), which are for the case in the presence of beta cells effect. This means that here
our modeling system can be applicable to both patients with type 2 diabetes case or with
moderate type 1 diabetes case since pancreatic beta cells can operate to some levels in such
cases. We carried out our investigation using both analytical and numerical methods to determine
the solution for the more general stated system.

4.1. Analytical solution & results
For G  P5 and G < Gb +, we considered both linear and nonlinear versions of the system (1a)(1e), and we solved them analytically which was done using separated variables or integration
factor approach. If G  P5 and G < Gb + hold starting at the initial time t=0, then we find that
both linear and nonlinear version of the system yield the same solution, which is given below:
G=Gb +[a0 /(P1 –b0)][exp(-b0 t)-exp(-P1 t)], I=Ib, X=0, r=0 for GP5 at t=0.

(3a-d)

By direct substitution, we proved that (3a-d) is the solution to the system (1a-e).
It can be seen from the solution (3a-d) that the plasma insulin concentration stays at its basal
value, and the insulin action and the secreted insulin by the pancreatic beta cells remain zero.
These results indicate that for the value of the plasma glucose concentration less than or equal a
threshold value, the insulin action, secreted insulin by beta cells as well as insulin concentration
are not effective since glucose in the plasma is not large enough that triggers extra insulin
production to counter the presence of glucose concentration in the plasma.
If GP5 and G< Gb+ initiate to hold at some value t0 >0 of time where G=G0, X=X0, r = r0 and
I=I0, then the same type of stated analytical approach yields the following solutions for the linear
case:
I=Ib+I0 exp[P6 (t0 –t)], r =r0 exp[a(t0 –t)],

(3e-f)

X=e2 exp(-P2 t)+e4 exp(-P6 t)+e5 exp(-a t),

(3g)

G=Gb+ e6 exp(-P1 t)+e7 exp(-P2 t)+e8 exp(-P6 t)+e9 exp(-a t)+ e10 exp(-b0 t),
where

(3h)
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e4 =[(I0 –Ib)P3 exp(P6 t0)]/(P2 –P6), e5 =[r0 P3 exp(a t0 )]/(P -a),
e2= X0 exp(P2 t)-e4 exp[(P2 –P6 ) t0]-e5 exp[(P2 –a)t0 ], e7 =Gb c2/(P1–P2),
e8= Gb c4/(P1–P6 ), e9 =Gb e5 /(P1 –a), e10 =a0 /(P1 –b0),
e6 =(G0 –Gb)exp(P1 t0)-e7 exp[(P1 –P2)t0]-e8 exp[(P1–P6)t0]A,
A – e9 exp[(P1 –a)t0]-e10 exp[(P1 –b0 )t0 ].
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(3i-j)
(3k-l)
(3m-n)
(3o)
(3p)

By direction substitution, we proved that the solution (3e-h) satisfies the linear version of (1a-e).
For the nonlinear system, the solution for each of the quantities r, I and X remain the same as the
corresponding one given in (3e-g). However, the solution for G needs to be found using a
different analytical method. We applied the method of integration factor (Pontryagin 1962) to
determine the expression for G(t). It is given below:
G(t)=Gb +{[0t (t)R(t)dt]+(G0 –Gb)(t0)}/[(t)],

(3q)

where
(t)=exp[P1 t+(e2/P2)exp(-P2 t)+(e4 /P6)exp(-P6 t)+(e5 /a)exp(-a t)],

(3r)

R(t)=Gb X(t)+a0 exp(-b0 t).

(3s)

For G>Gb +, then in general solutions need to be found numerically.
4.2. Numerical solution & results
For both G<P5 and G P5, the system is also solved numerically for both linear and nonlinear
cases using Euler’s method (Ascher et al. 1995). In the case of G< P5, we did check our
numerical results versus solution given in (3) to verify the numerical solution as well as to see
the reasonable value of the mesh distance, and we found very good agreement between
numerical and analytical form of the solution. Thus, it also verified our constructed code.
The present system of equations and initial conditions are for the time evolution of r, G, I and X
versus t. This system of differential equations represents the time rate of change of the
considered dependent variables (glucose and insulin concentrations in plasma, secreted insulin).
To carry out these simulations, we used some collected data for both normal person and diabetic
patients in order to determine the solution to (1a)-(1e) and then analyze the glucose-insulin
dynamics in the regulatory systems of these patients.
The values of the parameters and constants for three patients as well as for the normal case were
collected from some references (Ni et al. 1997; Mitsis et al. 2009; Hassan et al. 2017) and
already are given mostly in table 1. For the parameter values that are given in the equation (2d)
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for r, we used the values as given in Mitsis et al. (2009), which are a=0.13, =0.05 and two
values of 0 and 80 for .
Figure 11 presents the plasma glucose concentration versus time in the presence of the beta cells
effect and for the normal (healthy) person, patient 1 and patient 2. It can be seen from this Figure
that for the healthy person initially the plasma glucose concentration increases rapidly above its
basal value due to the initial delivered energy, and then it decreases strongly with increasing time
to reach its basal value and decreases further as time goes on, which is expected for a normal
person.
For the patient 1, plasma glucose concentration initially increases significantly and reaches a
maximum value higher than that for the normal person and then decreases less rapidly, but its
value remain higher than the corresponding value for the normal case, which is an indication of
some slight unstable condition mainly due to the smaller values of the parameters as compared to
the corresponding values for the patient 3 (table 1).
Table 1 also includes values of those parameters that represent the kinetic of the glucose and
insulin action, insulin sensitivity, enhancing insulin secretion and decay rate, and such smaller
values tends to reduce the glucose concentration at higher rate. For the patient 2, the values of
the glucose increase strongly at the initial stage with respect to time which can be due to the
lower values of the already stated parameters. It should also be noted that in the case of the
patient 2, we found the interaction between the insulin secretion due to the pancreatic beta cells
and the plasma glucose concentration existed mostly through the interval in time as shown in
Figure 11. This result is then led to lower values of the plasma glucose especially at higher
values of time, which is the effective role of such insulin secretion generated by the pancreatic
beta cells.

Figure 11. Glucose concentration versus time for normal person (dashed-dot line), patient 1 (dashed
line), patient 2 (solid line), Gb =80 and a0 =b0 =1.0, a=0.13, =0.05 and =0

Figure 12 is the same as Figure 11 but for the plasma insulin concentration versus time. It can be
seen from this Figure that in analogy to the results based on Figure 11 that we described above,
the insulin concentration increases slightly for the normal person, but the rate of change of the
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values of the plasma insulin concentration for the case of patient 2 increases significantly over
some interval in time and then begins to slightly increase thereafter, which is an indication of the
unstable behavior in the case of the patient 2 conditions. For the case of patient 1, the value of
the plasma insulin concentration appears to be small with a moderate increase with respect to
time and then decreases with increasing time, which is the direct effect by the presence of the
insulin secretion.

Figure 12. The same as in Figure 11 but for insulin concentration
Figure 13 presents the insulin action versus time in the presence of beta cells effect and for the
same patients and parameters values as those that were for Figure 11. In analogy to Figures 1112, the insulin action for the patient 2 ultimately becomes dominated as compared to the
corresponding cases for the normal person and the patient 1. In the cases of patient 1 and the
healthy person, the insulin action is relatively small because of the relatively larger values of the
parameters P2 –P6 in the case of such cases and also because of the positive value of the glucose

Figure 13. The same as Figure 11 but for insulin action
parameter P1 for the healthy person that reduces the rate of increase of the glucose concentration,
which subsequently reduces the insulin action.
Figure 14 is the same as Figure 11 but for the insulin secretion by the pancreatic beta cells. It can
be seen from this Figure that such secreted insulin is relatively small for the healthy person since
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there is no need that such secreted insulin to be significant for a normal case. However, the
secreted insulin by the pancreatic beta cells is significant at least over a notable time interval for
the cases of patient 1 and patient 2 in order to reduce the effect of the glucose concentration in
the plasma.

Figure 14. The same as in Figure 11 but for the insulin secretion due to the beta cells

Comparing the results that were described in this section and those in the section 3 for the same
patient, we find that the maximum value for the glucose concentration becomes smaller in the
presence of the beta cells than for the case in the absence of the beta cells, and then the values of
the glucose decreases more rapidly with increasing time in the presence of beta cells than for the
corresponding values for the case in the absence of the beta cells. The plasma insulin
concentration and the insulin action increase with time and reach higher values in the presence of
the beta cells. Thus, the efforts by the beta cells clearly makes the insulin more active that tends
to reduce the blood glucose, which has the direct benefit for the diabetes patient’s health.
4.3. Comparison with other studies
About the comparison of the present work with those of related work that were done by other
authors in the past, we consider here the work due to Hassan et al. (2017) and the one due to
Mitsis et al. (2009) that were already described in the section 1. Hassan et al. (2017) considered
the minimal model due to Bergman and Cobelli (1980) and used a controlling approach for an
external insulin delivery based on the linear version of the minimal model. Furthermore, in
contrast to the present work, these authors did not present the dynamical process of the hormones
and did not take into account the externally energy input, such as the one due to the consumed
food, on the patients’ hormones dynamics to determine the corresponding contribution to the
actual results. In addition, these authors did not include the governing equation for the secreted
insulin due to the pancreatic beta cells.
Mitsis et al. (2009) carried out a computational study for the glucose-insulin minimal modeling
system to develop a Volterra model. However, in contrast to the present work, they did not
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present the dynamical process of the hormones and did not include an equation for the insulin
concentration, but instead they just used a collection of numerical values to account for such
concentration. In addition, they also did not take into account any external energy input in their
studies.

5. Conclusions
We investigated both analytically and numerically the time evolution of a system of nonlinear
ordinary differential equations for the time-dependent variables that represented the plasma
glucose concentration, insulin action, plasma insulin concentration and the insulin secretion due
to the pancreatic beta cells and with externally added energy. We determined the variations of
these blood hormones versus time variable and for different values of the parameters that
represented different types of the patients with different health conditions. The effects of the
nonlinearities in the modeling system as well as the role of the presence of the externally
delivered energy to the considered glucose-insulin regulatory system were determined.
We found that the nonlinear effect in the investigated modeling system can increase the insulin
action and the glucose and insulin concentrations. Presence of the externally delivered energy to
the modeling system can increase the glucose concentration at some initial time interval, but the
insulin action and the insulin concentration quickly increase to reduce the blood glucose that was
raised up due to such added energy. In the presence of pancreatic beta cells, the glucose
concentration is lower than the corresponding one in the absence of the beta cells, and both
insulin action and insulin concentration appear to be more effective in the presence of the beta
cells. It is also found that smaller values of the parameters that represent kinetics of the glucose
and insulin concentration, insulin sensitivity and plasma insulin decay rate, can lead to relatively
lower values of the glucose concentration.
It would be of interest if the present results can stimulate future research efforts in the related
biomedical and biotechnological areas for developing new approach or process that could
improve the heath conditions of the patients with type 1 or type 2 diabetes cases.
Future studies in this subject area can include extending the present type modeling system by
including additional blood hormones in the regulatory system like those that can affect the
glucose concentration and the metabolic process to determine the time evolution of these
hormones in the regulatory system and how the glucose concentration is affected by the presence
of such additional hormones.
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